CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S EQUITY - USD ($)	Ordinary Shares [Member]	Subscription Receivables [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance as of April 29, 2024 (inception) at Apr. 28, 2024
Beginning balance, shares at Apr. 28, 2024
Issuance of representative shares
Issuance of ordinary shares to Sponsor	$ 1	(1)
Issuance of ordinary shares to Sponsor, shares	10,000
Ending balance, value at Jun. 30, 2024	$ 1	(1)
Ending balance, shares at Jun. 30, 2024	10,000
Balance as of April 29, 2024 (inception) at Dec. 31, 2024	$ 144		24,856	(10,299)	14,701
Beginning balance, shares at Dec. 31, 2024	1,437,500
Net income				(75,157)	(75,157)
Ending balance, value at Mar. 31, 2025	$ 144		24,856	(85,456)	(60,456)
Ending balance, shares at Mar. 31, 2025	1,437,500
Balance as of April 29, 2024 (inception) at Dec. 31, 2024	$ 144		24,856	(10,299)	14,701
Beginning balance, shares at Dec. 31, 2024	1,437,500
Proceeds allocated to Public Rights					(6,461,922)
Issuance of representative shares					493,482
Ending balance, value at Jun. 30, 2025	$ 175		8,838,190		8,838,365
Ending balance, shares at Jun. 30, 2025	1,747,325
Balance as of April 29, 2024 (inception) at Mar. 31, 2025	$ 144		24,856	(85,456)	(60,456)
Beginning balance, shares at Mar. 31, 2025	1,437,500
Net income				113,309	113,309
Proceeds allocated to Public Rights			6,461,922		6,461,922
Sale of private placement shares	$ 25		2,538,725		2,538,750
Sale of private placement shares, Shares	253,875
Issuance of representative shares	$ 6		493,476		493,482
Issuance of representative shares, Shares	55,950
Underwriters' discount			(121,614)		(121,614)
Other offering expenses			(29,460)		(29,460)
Recognition of over-allotment liability			(39,900)		(39,900)
Accretion of ordinary share subject to redemption value			(489,815)	(27,853)	(517,668)
Ending balance, value at Jun. 30, 2025	$ 175		$ 8,838,190		$ 8,838,365
Ending balance, shares at Jun. 30, 2025	1,747,325